134 related articles for article (PubMed ID: 31662314)
1. Adaptive trial designs: what are multiarm, multistage trials?
Millen GC; Yap C
Arch Dis Child Educ Pract Ed; 2020 Dec; 105(6):376-378. PubMed ID: 31662314
[No Abstract] [Full Text] [Related]
2. Adaptive Designs: Benefits and Cautions for Neurosurgery Trials.
Mukherjee A; Grayling MJ; Wason JMS
World Neurosurg; 2022 May; 161():316-322. PubMed ID: 35505550
[TBL] [Abstract][Full Text] [Related]
3. Adaptive multiarm multistage clinical trials.
Ghosh P; Liu L; Mehta C
Stat Med; 2020 Apr; 39(8):1084-1102. PubMed ID: 32048313
[TBL] [Abstract][Full Text] [Related]
4. Admissible multiarm stepped-wedge cluster randomized trial designs.
Grayling MJ; Mander AP; Wason JMS
Stat Med; 2019 Mar; 38(7):1103-1119. PubMed ID: 30402914
[TBL] [Abstract][Full Text] [Related]
5. Can emergency medicine research benefit from adaptive design clinical trials?
Flight L; Julious SA; Goodacre S
Emerg Med J; 2017 Apr; 34(4):243-248. PubMed ID: 27793963
[TBL] [Abstract][Full Text] [Related]
6. Multistage adaptive biomarker-directed targeted design for randomized clinical trials.
Gao Z; Roy A; Tan M
Contemp Clin Trials; 2015 May; 42():119-31. PubMed ID: 25778672
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of restricted randomization procedures for multiarm trials with equal or unequal treatment allocation ratios.
Ryeznik Y; Sverdlov O
Stat Med; 2018 Sep; 37(21):3056-3077. PubMed ID: 29869347
[TBL] [Abstract][Full Text] [Related]
8. Determining optimal sample sizes for multistage adaptive randomized clinical trials from an industry perspective using value of information methods.
Chen MH; Willan AR
Clin Trials; 2013 Feb; 10(1):54-62. PubMed ID: 23263520
[TBL] [Abstract][Full Text] [Related]
9. Some Lessons From 50 Years of Multiarm Public Policy Experiments.
Orr LL; Gubits D
Eval Rev; 2023 Feb; 47(1):43-70. PubMed ID: 33302732
[TBL] [Abstract][Full Text] [Related]
10. A Bayesian-adaptive decision-theoretic approach can reduce the sample sizes for multiarm exercise oncology trials.
Buffart LM; Bassi A; Stuiver MM; Aaronson NK; Sonke GS; Berkhof J; van de Ven PM
J Clin Epidemiol; 2023 Jul; 159():190-198. PubMed ID: 37245703
[TBL] [Abstract][Full Text] [Related]
11. Two-stage screened selection designs for randomized phase II trials with time-to-event endpoints.
Wu J; Pan H; Hsu CW
Biom J; 2022 Oct; 64(7):1207-1218. PubMed ID: 35661226
[TBL] [Abstract][Full Text] [Related]
12. Response-adaptive randomization for multiarm clinical trials using context-dependent information measures.
Kasianova K; Kelbert M; Mozgunov P
Biom J; 2023 Dec; 65(8):e2200301. PubMed ID: 37816142
[TBL] [Abstract][Full Text] [Related]
13. Using Bayesian adaptive designs to improve phase III trials: a respiratory care example.
Ryan EG; Bruce J; Metcalfe AJ; Stallard N; Lamb SE; Viele K; Young D; Gates S
BMC Med Res Methodol; 2019 May; 19(1):99. PubMed ID: 31088354
[TBL] [Abstract][Full Text] [Related]
14. Attitudes and opinions regarding confirmatory adaptive clinical trials: a mixed methods analysis from the Adaptive Designs Accelerating Promising Trials into Treatments (ADAPT-IT) project.
Meurer WJ; Legocki L; Mawocha S; Frederiksen SM; Guetterman TC; Barsan W; Lewis R; Berry D; Fetters M
Trials; 2016 Jul; 17():373. PubMed ID: 27473126
[TBL] [Abstract][Full Text] [Related]
15. Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency.
Collignon O; Koenig F; Koch A; Hemmings RJ; Pétavy F; Saint-Raymond A; Papaluca-Amati M; Posch M
Trials; 2018 Nov; 19(1):642. PubMed ID: 30454061
[TBL] [Abstract][Full Text] [Related]
16. Exploratory trials in mental health: anything to learn from other disciplines?
Trelle S
Evid Based Ment Health; 2017 Feb; 20(1):21-24. PubMed ID: 28073811
[TBL] [Abstract][Full Text] [Related]
17. Comparison of response adaptive randomization features in multiarm clinical trials with control.
Viele K; Saville BR; McGlothlin A; Broglio K
Pharm Stat; 2020 Sep; 19(5):602-612. PubMed ID: 32198968
[TBL] [Abstract][Full Text] [Related]
18. Bayesian adaptive clinical trial designs for respiratory medicine.
Ryan EG; Couturier DL; Heritier S
Respirology; 2022 Oct; 27(10):834-843. PubMed ID: 35918280
[TBL] [Abstract][Full Text] [Related]
19. Expected Value of Sample Information to Guide the Design of Group Sequential Clinical Trials.
Flight L; Julious S; Brennan A; Todd S
Med Decis Making; 2022 May; 42(4):461-473. PubMed ID: 34859693
[TBL] [Abstract][Full Text] [Related]
20. Estimation of treatment effects following a sequential trial of multiple treatments.
Whitehead J; Desai Y; Jaki T
Stat Med; 2020 May; 39(11):1593-1609. PubMed ID: 32207166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
